escitalopram oxalate
- Product NDC
- 10544-225
- 11-digit product format
- 105440225
- Labeler code
- 10544
- Product ID
- 10544-225_ec5c6a1e-a9e8-4b74-8175-960063bcd1a2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- escitalopram oxalate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Blenheim Pharmacal, Inc.
- Application
- ANDA090939
- Marketing category
- ANDA
- Marketing start
- 2013-11-15
- Marketing end
- 0000-00-00
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10544-225-30 | escitalopram oxalate | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ESCITALOPRAM OXALATE | ACTIVE INGREDIENT | 5U85DBW7LO | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ESCITALOPRAM | ACTIVE MOIETY | 4O4S742ANY | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10544-225 | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | Legacy NDC, 1 package rows | 20150217_ec5c6a1e-a9e8-4b74-8175-960063bcd1a2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10544-225-30 | 10544022530 | 30 in 1 BOTTLE | Historical |